Concepedia
Statistics
Publications
19
Citations
1.1K
H-Index
17
Active since
1990
Affiliations
SynZyme Technologies (United States)(Current)
Howard Hughes Medical Institute
Molecular Oncology (United States)
University of Iowa
University of California, Davis
Michael A. Perricone is an author at SynZyme Technologies (United States) specializing in immunology, life sciences, and molecular biology.
Publications per year
1990–2011
A Clinical Inflammatory Syndrome Attributable to Aerosolized Lipid–DNA Administration in Cystic Fibrosis
F. Ruiz, John P. Clancy, Michael A. Perricone et al. · Human Gene Therapy · 2001 · 184 citations
Life Sciences, Immunology, Molecular Biology +17
Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.
Joseph Zabner, Shuk Han Cheng, David P. Meeker et al. · Journal of Clinical Investigation · 1997 · 177 citations · Full text
Pharmacy, Genetics, Molecular Biology +17
Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
Shingo Takano, Stephen Gately, Mary E. Neville et al. · PubMed · 1994 · 132 citations
Medicine, Pharmacology, Biochemical Pharmacology +12
Aerosol and Lobar Administration of a Recombinant Adenovirus to Individuals with Cystic Fibrosis. I. Methods, Safety, and Clinical Implications
Patricia M. Joseph, Brian O’Sullivan, Allen Lapey et al. · Human Gene Therapy · 2001 · 100 citations
Medicine, Molecular Biology, Molecular Medicine +17
Aerosol and Lobar Administration of a Recombinant Adenovirus to Individuals with Cystic Fibrosis. II. Transfection Efficiency in Airway Epithelium
Michael A. Perricone, James E. Morris, K Pavelka et al. · Human Gene Therapy · 2001 · 92 citations
Pharmacy, Molecular Biology, Molecular Medicine +17
1–5 of 19